00-8-075
| 规格 | 目录价格 | 上海 | 安徽 | 武汉 | 成都 | 北方 | 深圳 | 会员价格 | 数量 |
|---|---|---|---|---|---|---|---|---|---|
| 00mg | ￥ ňĭđŘŘ | -- | -- | -- | -- | -- | ￥ ňĭđŘŘ | - + | |
| 50mg | ￥ ǪŘưđŘŘ | -- | -- | -- | -- | -- | -- | ￥ ǪŘưđŘŘ | - + |
| g | ￥ ĭĭňđŘŘ | -- | -- | -- | -- | -- | -- | ￥ ĭĭňđŘŘ | - + |
| 5g | ￥ ňĊNjđŘŘ | -- | -- | -- | -- | -- | -- | ￥ ňĊNjđŘŘ | - + |
| 0g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
| 5g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
| 00g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
59.8
[]. A G Hayes, et al. Determination of ,5-dihydro-6-[-(H-imidazol--yl) phenyl]-3(H)-pyridazinone hydrochloride, a new cardiotonic, in plasma and urine by reversed-phase high-performance liquid chromatography. J Chromatogr. 98 Dec ;336():6-5.
[]. A Hartmann, et al. [Phosphodiesterase inhibition as a new positive-inotropic principle]. Dtsch Med Wochenschr. 986 Dec 9;(5-5):97-7.
[3]. A Hartmann, et al. Effect of a new phosphodiesterase type III inhibitor as a coronary vasodilator and positive inotropic agent. Cardiovasc Res. 987 Aug;(8):593-600.
[]. B Zhang, et al. Effects of glaucocalyxin A on aggregation and cAMP levels of rabbit platelets in vitro. Zhongguo Yao Li Xue Bao. 993 Jul;():37-50.
[5]. J A Allert, et al. Inotropic and chronotropic profile of MCI-5: comparison with isoproterenol and imazodan in guinea pig cardiac preparations. J Cardiovasc Pharmacol. 990 Jul;6():59-67.
H30-H35-H39-H335
P6-P6-P70-P7-P80-P30+P35-P30+P30-P330-P36+P36-P05-P50
05500 货期咨询
￥ ĭĭƦƦđŘŘ -5g
3363 货期咨询
￥ ĭĜĜƦđŘŘ -00mg
357 货期咨询
￥ ǪǪĭƦĢđŘŘ -0g
37887 货期咨询
￥ ĜňňđŘŘ -5g
59 货期咨询
￥ ǪŘƦĊĊđŘŘ -g
38068 货期咨询
￥ ǪǪĭưđŘŘ -50mg
695 货期咨询
￥ ǪǪĢǪĜđŘŘ -g
583 货期咨询
￥ ǪǪňĭNjđŘŘ -500mg
309 货期咨询
￥ ĜňĊĊđŘŘ -g
533 货期咨询
沪ICP备70965号
